Compositions and methods for delivering cannabidiol and ketone bodies
Disclosed herein are “ketonnabidiol” or “ketannabidiol” compositions including a combination of: (1) cannabidiol (CBD) and/or cannabidiolic acid (CBDA); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketonnabidiol compositions for producing desired physiological effects, such as fat loss, in a mammal. The ketonnabidiol compositions beneficially enhance fat loss through ketosis while also reducing the duration and/or severity of unpleasant “keto flu” symptoms typically associated with ketosis.
1. A composition comprising:
at least one ketone body component selected from one or more beta-hydroxybutyrate (BHB) salts, one or more BHB esters, BHB acid, one or more acetoacetate salts, acetoacetic acid, and combinations thereof, wherein the one or more beta-hydroxybutyrate (BHB) salts are selected from the group consisting of alkali metal BHB salts, alkaline earth metal BHB salts, and amino acid BHB salts; and
cannabidiol (CBD),
wherein the composition is in a dosage form that provides from about 0.5 gram to about 50 grams of the ketone body component and about 3 mg to about 1 dram of the CBD,
wherein the composition includes a ratio of the ketone body component to the CBD in a range about 6:1 to about 6,000:1 by weight.
2. The composition of claim 1 , further comprising one or more additional cannabinoid compounds derived from the cannabis plant selected from tetrahydrocannabivarin (THCV), cannabigerol (CBG), cannabidivarin (CBDV), cannabichromene (CBC), cannabinol (CBN), cannabielsoin (CBE), tetrahydrocannabinol (THC), iso-THC, cannabicyclol (CBL), cannabicitran (CBT), cannabivarin (CBV), cannabichromevarin THC (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM), a carboxylic acid form of a cannabinoid, and combinations thereof.
3. The composition of claim 1 , further comprising one or more components selected from 1,3-butanediol, a fatty acid, an ester of the fatty acid, a medium chain fatty acid, an ester of the medium chain fatty acid, a short chain fatty acid, or an ester of the short chain fatty acid.
4. The composition of claim 1 , wherein the composition is provided in solid or powder form.
5. The composition of claim 1 , wherein the composition is provided in liquid form.
6. The composition of claim 1 , wherein the dosage form provides from about 1 gram to about 40 grams of the ketone body component and about 10 mg to about 600 mg of the CBD.
7. The composition of claim 1 , further comprising a pharmaceutically or dietetically acceptable carrier.
8. A composition comprising:
a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetic acid, and combinations thereof; and
cannabidiol (CBD),
wherein the composition is in an oral dosage form that provides a unit dose of about 0.5 grams to about 50 grams of the ketone body component and a unit dose of about 3 mg to about 1 gram of the CBD,
wherein the composition includes a ratio of the ketone body component to the CBD in a range about 6:1 to about 6,000:1 by weight.
9. The composition of claim 8 , wherein the composition includes a ratio of the ketone body component to the CBD in a range about 9:1 to about 4,000:1 by weight.
10. A kit for administering ketone bodies and cannabidiol (CBD) to a mammal, comprising:
a composition in solid or powder form comprised of:
a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetic acid, and combinations thereof; and
CBD,
wherein the composition includes a ratio of the ketone body component to the CBD in a range about 6:1 to about 6,000:1 by weight;
a container in which the composition is placed; and
a measuring device configured to hold therein a unit dose, or fraction thereof, of the composition, wherein a unit dose of the composition contains about 0.5 gram to about 50 grams of the ketone body component and about 3 mg to about 1 gram of the CBD.
11. The kit of claim 10 , wherein a unit dose of the composition contains about 1 gram to about 40 grams of the ketone body component and about 10 mg to about 600 mg of the CBD.
12. The composition of claim 8 , wherein the unit dose of the composition when administered to a mammal provides one or more of homeostasis promotion, neuroprotection, memory enhancement, an anxiolytic effect, an anti-depressant effect, an anti-inflammatory effect, an analgesic effect, an antioxidant effect, blood pressure modulation, heart rate modulation, an anti-tumorigenic effect, a longevity promoting effect, weight loss, fat loss, appetite suppression, fat browning, increased lipolysis, or sleep promotion.
13. The composition of claim 1 , wherein the CBD functions to counteract serotonin reduction associated with administration of the ketone body component.
14. The composition of claim 1 , wherein the ketone body component increases the pharmacokinetic utilization of the CBD relative to pharmacokinetic utilization of the CBD in the absence of the ketone body component.
15. The composition of claim 1 , wherein the composition when administered to a mammal accelerates the production of endogenous ketones in the subject as a result of increased availability of ketone body precursors.
16. The composition of claim 1 , wherein the composition when administered to a mammal enhances function of the endocannabinoid system in the mammal.
17. The composition of claim 1 , wherein the dosage form is configured to be administered by one or more of ingestion, intragastric, injection, topical, inhalation, oral mucosal, rectal, vaginal, or parenteral.
18. The composition of claim 1 , wherein the composition includes a ratio of the ketone body component to CBD in a range about 9:1 to about 4,000:1 by weight.
19. The kit of claim 10 , wherein the composition includes a ratio of the ketone body component to CBD in a range about 9:1 to about 4,000:1 by weight.